Safety and immunogenicity of inactivated, Vero cell culture-derived whole virus influenza A/H5N1 vaccine given alone or with aluminum hydroxide adjuvant in healthy adults-Reference-Cited by-同舟云学术

Safety and immunogenicity of inactivated, Vero cell culture-derived whole virus influenza A/H5N1 vaccine given alone or with aluminum hydroxide adjuvant in healthy adults

Published:2009-11 Issue:47 Volume:27 Page:6642-6648
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Keitel Wendy A.,Dekker Cornelia L.,Mink ChrisAnna,Campbell James D.,Edwards Kathryn M.,Patel Shital M.,Ho Dora Y.,Talbot Helen K.,Guo Kuo,Noah Diana L.,Hill Heather

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference26 articles.

1. Flu-vaccine makers toil to boost supply;Dennis;Nature,2006

2. Preparing for a possible pandemic; influenza A/H5N1 vaccine development;Keitel;Curr Opin Pharmacol,2007

3. Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial;Bresson;Lancet,2006

4. Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given without or with aluminum hydroxide to healthy adults: results of a phase I–II randomized clinical trial;Keitel;J Infect Dis,2008

5. Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults;Nolan;Vaccine,2008

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity and safety of varying dosages of a fifth-wave influenza A/H7N9 inactivated vaccine given with and without AS03 adjuvant in healthy adults;Vaccine;2024-01

2. A TLR9 agonist synergistically enhances protective immunity induced by an Alum-adjuvanted H7N9 inactivated whole-virion vaccine;Emerging Microbes & Infections;2023-08-28

3. A Multi-Center, Controlled Human Infection Study of Influenza A (H1N1)pdm09 in Healthy Adults;2022-10-04

4. Aluminium adjuvants versus placebo or no intervention in vaccine randomised clinical trials: a systematic review with meta-analysis and Trial Sequential Analysis;BMJ Open;2022-06

5. Safety and immunogenicity of monovalent H7N9 influenza vaccine with AS03 adjuvant given sequentially or simultaneously with a seasonal influenza vaccine: A randomized clinical trial;Vaccine;2022-05